▸ THE LION × HEALTHCARE & LIFE SCIENCES
How The Lion sells to Healthcare CROs & Life-Sciences VPs
Risk-averse, compliance-heavy buyers where deal cycles bend around procurement committees, clinical timelines, and regulatory windows.
The Lion in 30 seconds
Archetype profileDominant, decisive, and commercially sharp — you thrive on winning. Your instinct is to close, and your pipeline reflects strong late-stage momentumHealth · GlossaryDeal MomentumThe directional change in a deal's engagement and activity over the last 14–30 days. Positive momentum (rising activity, multi-threading expanding, response times shrinking) is one of the strongest predictors of close. Negative momentum is one of the strongest predictors of slip.View full definition →.
What Healthcare CROs & Life-Sciences VPs actually care about
Buyer pains
- •Clinical operations teams drowning in manual data reconciliation
- •Compliance overhead slowing time-to-revenue for new programmes
- •Fragmented data across CTMS, EDC, and finance systems
Buying signals
- •Clinical, IT and Procurement attend the same call with aligned questions
- •Buyer references their internal AI / data governance policy unprompted
- •A pilot proposal with success criteria is requested in writing
Why The Lion wins in Healthcare & Life Sciences
- Strong commercial control of deals
- Confident negotiation under pressure
- Drives urgency and creates deadlines
- Decisive — moves deals to closure
Where The Lion slips when selling Healthcare & Life Sciences
- Can force deals that aren't ready
- May overlook deeper qualification signals
- Risk of over-promising to win
- Can lose rapport by pushing too hard
▸ Pipeline insight
Lion profiles often show strong late-stage momentum, but may overestimate deal health if qualification is rushed. Watch for deals that 'close' but churn early.
Objections you'll hit in Healthcare & Life Sciences
"Our InfoSec / GxP review will take 4–6 months"
"We need a peer reference from a comparable CRO before we can move"
Enterprise healthcare deals typically run 6–12 months, with InfoSec, legal and clinical sign-off as the three biggest drag points.
The Lion's Healthcare & Life Sciences playbook
- 01Validate buying criteria before entering negotiation stage
- 02Build mutual close plans with the buyer — not just internal timelines
- 03Review lost deals quarterly to identify forced-close patterns
▸ Predara for Healthcare & Life Sciences
Turn this playbook into pipeline truth
Predara generates mutual close plans from your pipeline data and flags deals where qualification gaps risk early churn.